Antiproliferative benzothiazoles incorporating a trimethoxyphenyl scaffold as novel colchicine site tubulin polymerisation inhibitors
Tubulin polymerisation inhibitors exhibited an important role in the treatment of patients with prostate cancer. Herein, we reported the medicinal chemistry efforts leading to a new series of benzothiazoles by a bioisosterism approach. Biological testing revealed that compound 12a could significantl...
Saved in:
Main Authors: | Dong-Jun Fu (Author), Si-Meng Liu (Author), Fu-Hao Li (Author), Jia-Jia Yang (Author), Jun Li (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cytotoxic substituted indolizines as new colchicine site tubulin polymerisation inhibitors
by: Monica-Cornelia Sardaru, et al.
Published: (2020) -
3-aryl-4-(3,4,5-trimethoxyphenyl)pyridines inhibit tubulin polymerisation and act as anticancer agents
by: Chao Wang, et al.
Published: (2024) -
Discovery of dual tubulin-NEDDylation inhibitors with antiproliferative activity
by: Dong-Jun Fu, et al.
Published: (2023) -
A review on synthetic chalcone derivatives as tubulin polymerisation inhibitors
by: Wenjing Liu, et al.
Published: (2022) -
Design, synthesis and biological evaluation of novel diarylpyridine derivatives as tubulin polymerisation inhibitors
by: Shanbo Yang, et al.
Published: (2022)